Viridian Therapeutics, Inc.VRDNNASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+241.4%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+241.4%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
39.8x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$70.53M+23254.0%
2024$302000.00-3.8%
2023$314000.00-82.3%
2022$1.77M-40.2%
2021$2.96M+110.9%
2020$-27.25M-710.9%
2019$4.46M+120.2%
2018$-22.04M-41.1%
2017$-15.62M-2079.7%
2016$789000.00-